Review

blood test (Freenome Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Freenome Inc blood test
Blood Test, supplied by Freenome Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blood+test/blood+test/nct06122077-8-6-6
Average 90 stars, based on 1 article reviews

blood test - by Bioz Stars, 2026-09

90/100 stars

Images

Methylation:

Article Title: Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy
Article Snippet: By decoding the complex cell-free biomarker model, Freenome’s blood tests are powered by their multigroup platform and designed to detect cancer in its early stages to help clinicians optimize the next generation of precision therapies. .. Freenome’s multi-group blood test approach combines cell-free cancer biology and machine learning to perform accurate early cancer screening by analyzing cfDNA, methylation, proteins and other biomarkers in plasma and decoding complex patterns associated with the body’s response to specific tumor types. .. At present, according to Freenome in the ASCO released gastrointestinal cancer symposium “Using multicomponent and machine learning for colorectal cancer early detection based on blood”( https://www.freenome.com/news-resources , accessed on 12 May 2022), the blood test has a sensitivity of 94% for the detection of early CRC.

Clinical Proteomics:

Biomarker Discovery:

Article Title: Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy
Article Snippet: Freenome’s multi-group blood test approach combines cell-free cancer biology and machine learning to perform accurate early cancer screening by analyzing cfDNA, methylation, proteins and other biomarkers in plasma and decoding complex patterns associated with the body’s response to specific tumor types. .. At present, according to Freenome in the ASCO released gastrointestinal cancer symposium “Using multicomponent and machine learning for colorectal cancer early detection based on blood”( https://www.freenome.com/news-resources , accessed on 12 May 2022), the blood test has a sensitivity of 94% for the detection of early CRC. .. Freenome’s multi-component blood test was also compared with the leading fecal immunochemistry test (FIT), which showed a sensitivity of 100% for the multi-component blood test and 67% for the FIT.

other:

Article Title: The PROACT LUNG Study: A Prospective, Observational,Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening (FRNM-007)
Article Snippet: Measure Description: Clinical performance of the Freenome Blood Test, including sensitivity and specificity, in detecting lung cancer in subjects with positive and negative lung cancer outcomes during a 12-month follow-up period.